Human Insulin Inhalation Powder
Sponsors
Eli Lilly and Company
Conditions
AsthmaDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Pulmonary Disease, Chronic Obstructive
Phase 2
Phase 3
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
CompletedNCT00127634
Start: 2005-07-31End: 2008-05-31Updated: 2018-03-09
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
CompletedNCT00157339
Start: 2005-08-31End: 2008-05-31Updated: 2019-09-17
Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
CompletedNCT00325364
Start: 2006-04-30End: 2008-05-31Updated: 2019-09-16
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
CompletedNCT00330473
Start: 2006-06-30End: 2008-05-31Updated: 2019-09-16
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
CompletedNCT00355849
Start: 2006-08-31End: 2008-06-30Updated: 2019-09-16
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
CompletedNCT00356109
Start: 2006-08-31End: 2008-05-31Updated: 2018-03-09
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
CompletedNCT00437112
Start: 2007-02-28End: 2008-05-31Updated: 2018-03-09